MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Testing for the “whack-a-mole” sign in the movement disorders clinic

    J.E. Park, C. Maurer, M. Villegas, M. Hallett (Bethesda, MD, USA)

    Objective: We aimed to determine the sensitivity and specificity of the “whack-a-mole” sign in our movement disorders clinic population. Background: The “whack-a-mole” sign, characterized as…
  • 2016 International Congress

    Colonic α-synuclein: A potential diagnostic biomarker in Parkinson’s disease

    C. Ruffmann, I. Poggiolini, N. Bengoa-Vergniory, F. Baig, M. Rolinski, J. Klein, M.T. Hu, R. Wade-Martins, J. Alegre-Abarrategui, L. Parkkinen (Oxford, United Kingdom)

    Objective: To validate detection of α-synuclein pathology in the gastrointestinal (GI) tract as a diagnostic marker of Parkinson's disease (PD). Background: α-synuclein (ASN) deposition in…
  • 2016 International Congress

    Effects of movement rate and amplitude on repetitive finger motion in people with Parkinson’s disease and freezing of gait

    M.P. Pereira, S. Vercruysse, E. Heremans, A. Nieuwboer (Leuven, Belgium)

    Objective: To evaluate the role of movement amplitude and rate on spatiotemporal parameters and EMG response during a rhythmic and continuous finger-tapping paradigm in people…
  • 2016 International Congress

    Reliability of the sensory organization test to predict falls in individuals with Parkinson’s disease

    T.E. Apoznanski, S. Yao, M.K. Jung, J. DiFrancisco-Donoghue (Old Westbury, NY, USA)

    Objective: To determine the ability of the Sensory Organization Test (SOT) to predict falls in individuals with Parkinson's disease (PD). Background: Individuals with PD are…
  • 2016 International Congress

    Psychogenic non-epileptic seizures among patients with temporal lobe and other epilepsies: Phenomenology and EEG correlates

    B.D. Wissel, A.K. Dwivedi, T.E. Gaston, F.J. Rodriguez-Porcel, D. Al Jaafari, J.L. Hopp, A. Krumholz, Y. Wang, S.M.A. van der Salm, D.M. Andrade, F. Borlot, B.D. Moseley, J.L. Cavitt, S. Williams, J. Stone, W.C. LaFrance Jr, J.P. Szaflarski, A.J. Espay (Cincinnati, OH, USA)

    Objective: To determine the extent to which cortical epileptic foci of patients with comorbid psychogenic non-epileptic and epileptic seizures (PNES/ES) differ from age- and gender-matched…
  • 2016 International Congress

    Autophagic modulation by rosuvastatin prevent rotenone induced neurotoxicity as an in vitro model of Parkinson’s disease

    W. Jang (Gangneung, Korea)

    Objective: We investigated effects of statin on autophagy markers and evaluated the neuroprotective effect of rosuvastatin from rotenone induced neurotoxicity. Background: Recently, autophagy pathway is…
  • 2016 International Congress

    Dopaminergic medication effect on speech in Parkinson’s disease: A kinematic study

    T.E. Tong, M.L. Ng, N. Yan (Hong Kong, Hong Kong)

    Objective: To investigate the effect of levodopa on articulatory movement during Cantonese plosive production in individuals with Parkinson's disease (PD) by comparing kinematic parameters before…
  • 2016 International Congress

    Validity and reliability of the test d evaluation des membres superieurs de personnes agees (TEMPA) to assess upper limb in Parkinson’s disease

    C.L. Correa, P.R. de-Freitas, A.E. Lemos, S.M. Michaelsen, A. Swarowsky (Rio de Janeiro, Brazil)

    Objective: This study aims to carry out validity and reliability of the Test dEvaluation des Membres Superieurs Des Personnes Agees (TEMPA) in patients with PD.…
  • 2016 International Congress

    AntiParkinsonian treatment patterns and motor complications among patients with Parkinson´s disease in Estonia

    L. Kadastik-Eerme, N. Taba, P. Taba (Tartu, Estonia)

    Objective: To evaluate pharmacological treatment patterns in patients with Parkinson´s disease (PD), prevalence of motor complications, and factors associated with them. Background: Levodopa is the…
  • 2016 International Congress

    Progress in the development of small molecules based on the coumarin core as multifunctional neuroprotective agents

    M.J. Matos, D. Viña, F. Rodríguez-Enríquez, S. Vilar, L. Santana, E. Uriarte (Santiago de Compostela, Spain)

    Objective: Taking into account the background of our research group and the knowledge that MAO and ChE activity generates ROS that cause neuronal cell death,…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Unusual prolonged survival in multiple system atrophy: A case report
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley